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P. M. GISORE and R. C. VREEMAN
ABSTRACT
Objectives: To describe the characteristics and outcomes of children registered for care 
in a large HIV care programme in Western Kenya. 
Design: A retrospective descriptive study. 
Setting: USAID-AMPATH HIV clinics in health centres; district and sub-district 
hospitals; Moi Teaching and Referral Hospital in Western Kenya. 
Subjects: HIV-infected children below age of 15 years seen in a network of 18 clinics 
in Western Kenya.
Interventions: Paediatric HIV diagnosis and care including treatment and prevention 
of opportunistic infections and provision of combination antiretroviral therapy 
(CART). 
Main outcome measures: Diagnosis, clinical stage and immune status at enrollment 
and follow-up; hospitalisation and death. Descriptive statistical analyses and chi 
square tests were performed
Results: Four thousand and seventeen HIV-infected children seen between June 2002 
and April 2008. Median age at enrollment was four years (0-14.2 years), 51% girls, 25% 
paternal orphans, 10% total orphans and 13% maternal orphans.  At enrollment, 25% had 
weight-for-Age Z scores (WAZ)> -1 and 21% had WAZ scores < 3. Orphaned children had 
worse WAZ scores (p=0.0001). Twenty ﬁve per cent of children were classiﬁed as WHO 
clinical stage 3 and 4, 56% were WHO clinical stages 1 and 2 with 19% missing clinical 
staging at enrollment. Cough (25%), gastroenteritis (21%), fever (15%), pneumonia (10%) 
were the commonest presenting features. Twenty six per cent had been diagnosed with 
tuberculosis and only 25% started on cotrimoxazole preventive therapy (CPT). Median 
CD4% at enrollment was 16% (0-64%); latest recorded values were 22% (0-64). Sixty four 
per cent were on cART (cART+), median age at start was 5.4 (014.4 years).The median 
initial CD4% among cART+ was 13 (0-62) compared to 24 (0-64) for those not on ART 
(cART-). Median CD4% for cART+ improved to 22% (0-59); whereas cART- was 23% (0-
64) at last appointment. During the period of follow-up, one ﬁfth (19%) of children on 
cART were lost to follow-up compared to slightly over one third (37%) for those not on 
cART. Thirty four percent were hospitalised; 41% diagnosed with pneumonia. Six per 
cent of 4017 were conﬁrmed dead.
Conclusions: HIV -infected children were enrolled in care early in childhood. Orphan-
hood was prevalent in these children as were gastroenteritis, fever, pneumonia and 
advanced immuno-suppression. Orphans were more likely to be severely malnourished. 
Only a quarter of children were put on cotrimoxazole preventive therapy. Children 
commenced on cART late but responded well to treatment. Loss to follow-up was less 
prevalent among those on cART.
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INTRODUCTION
In the last two decades, the Acquired Immune 
Deﬁciency Syndrome (AIDS) epidemic that is caused by 
the Human Immunodeﬁciency Virus (HIV) has swept 
through sub-Saharan Africa with venom. According 
to the UNAIDS- www.unaids.org- there are 33.2 million 
people living with HIV, 22.5 million of them being 
in sub-Saharan Africa and 2.5 million being children 
under 15 years. In 2007 alone, there were 420,000 
newly infected children worldwide with 330,000 
children dying (1). In Kenya, over 1.3 million people 
are HIV infected, including over 150,000 children. 
The adult prevalence has apparently declined from 
a high of 15% in 1998 to a current low of 7.8 % (2). 
Stabilised infection levels in this epidemic may be due 
to improved prevention but also often result from rising 
death rates from AIDS which conceal a continuing 
high rate of new infections. There are over 1,100,000 
orphans in Kenya due to parental HIV-infection and 
death. In 2005 alone, over 140,000 people died from 
HIV/AIDS in the country. HIV infection is one of the 
top ﬁve causes of mortality in Kenya and has greatly 
contributed to the under-ﬁve mortality rate rising from 
112 in 1998 to 120 per 1000 in 2004 (3).
 HIV-related symptoms and signs are rarely 
present at birth, but develop over subsequent 
months or years (4). In about a quarter of infected 
children, HIV infection progresses rapidly to AIDS 
or death in the ﬁrst year (4,5). In the remainder, it 
progresses more slowly, with some HIV-infected 
children surviving child hood (6). The proportion 
of patients who have rapid progression of disease 
is higher in children than in adults. In the European 
collaborative study, mortality in HIV infected infants 
was 15%, and mortality by the age of ﬁve years was 
28%, ﬁndings similar to those in the Italian study (6). 
According to the European experience, the annual 
rate of progression to AIDS decreases after the ﬁrst 
year to approximately 6-8%, as does the mortality 
rate (5,6). 
 The morbidities of HIV-infected children may 
vary by geographical location. HIV -infected children 
in Africa frequently suffer from pneumonia, diarrhoea, 
bacteremia, failure to thrive and lymphadenopathy. 
In Cote d’Ivoire, among 338 consecutively admitted 
HIV-infected children, 26% had respiratory infections 
and 26% had malnutrition (7). In South Africa, among 
48 children with vertically transmitted HIV infection 
followed for 26 months, 78% had diarrhoea, 76% 
pneumonia and 70% lymphadenopathy. Twenty ﬁve 
per cent died at a mean age of 10 months (but up 
to 48 months); the top four diagnoses at the time of 
death being dirrhoea, pneumonia, failure to thrive 
(FTT) and severe oral thrush (8). Mortality is also 
consistently higher among hospitalised children who 
are HIV-positive than those who are HIV-negative. 
The mortality rate among 354 HIV positive children 
aged between six months and ﬁve years hospitalised 
in Zambia was 19%, a rate signiﬁcantly higher than 
the mortality rate of 9% among 912 hospitalised, 
HIV-negative children (9). 
 The effect of combination antiretroviral therapy 
(cART) on the disease progression and outcomes of 
HIV-infected children in Africa has not been well-
studied, in part because few children are on cART. 
At the end of 2006, the WHO estimated that 115,000 
children had access to HIV treatment a coverage rate 
of about 15%. In Kenya, only about 90,000 patients 
are on cART, out of an eligible population of over 
750,000, with only 13,000 being children (10). Thus, 
data on African children’s cART outcomes are just 
beginning to accumulate. In pooled data studying 
392 children on cART in resource-limited settings 
including Africa, the median gain in CD4% was 8.2 at 
6 months (n=48, IQR: 4.8-12.6) and 10.2 at 12 months 
(n=12, IQR: 6.6-16.3). The median Weight-for-Age Z 
score (WAZ) gain was +0.89 at 6 months and +0.92 
at 12 months. Mortality over time was 7.8% (11). In a 
study in Western Kenya, children on cART had a good 
response irrespective of their orphan status, with the 
only remarkable ﬁnding being a lag in weight gain 
among the orphans on cART (12).
 Moi University School of Medicine, in 
collaboration with Moi Teaching and Referral 
Hospital (MTRH), has recognised the pivotal role their 
institutions must play in Kenya’s overall response to 
the threat presented by HIV-AIDS pandemic. These 
institutions, in partnership with Indiana University 
School of Medicine and USAID, established the 
USAID-Academic Model for the Prevention and 
Treatment of HIV-AIDS, now known as the USAID-
Academic Model Providing Access to Healthcare 
(USAID-AMPATH) (13). USAID-AMPATH embraces 
excellent patient care, education of patients, medical 
and nursing students, research and rural health centre 
participation. As Kenya implements anti-retroviral 
therapy in persons infected with the HIV virus, 
USAID-AMP A TH has provided care for over 89,000 
patients, including over 16,000 children. The USAID-
AMPATH cohort of patients provides an optimal 
setting in which to describe HIV-related outcomes 
for Paedriatic patients in East Africa. 
 We need to examine the demographic and 
clinical characteristics, morbidities and outcomes 
for HIV-infected children in East Africa. Such studies 
will inform strategic protocols and improve the 
efﬁcacy of HIV care and management. Describing 
HIV-related characteristics and outcomes for our 
cohort of HIV -infected children will not only 
beneﬁt the thousands of children followed by the 
USAID-AMPATH programme, but will also provide 
important information for Kenya, the East African 
region, and beyond. 
 The main objective of the study was to describe the 
demographic and clinical characteristics; diagnoses; 
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treatment and follow-up outcomes among a cohort 
of HIV-infected children in care at a large HIV care 
programme in Western Kenya.
MATERIALS AND METHODS
Study design: This was a retrospective descriptive 
study. We used prospectively collected de-identiﬁed 
data from the computerised medical records of HIV 
-infected paedriatic patients treated in the USAID- 
AMPATH clinical care system in Western Kenya. The 
study was approved by the Institutional Research 
and Ethics Committee of the Moi University School 
of Medicine and Moi Teaching and Referral Hospital 
(Eldoret, Kenya) and the Institutional Review 
Board of the Indiana University School of Medicine 
(Indianapolis, IN). 
Study site: USAID-AMPATH operates an urban 
referral clinic at the Moi Teaching and Referral 
Hospital (MTRH) in Eldoret, Kenya, a national 
tertiary referral hospital serving a catchments area 
of approximately 13 million people. Comprehensive 
HIV care services for children are also provided at 17 
outlying outpatient clinics (Mosoriot, Turbo, Burnt 
Forest, Amukura, Naitiri, Chulaimbo, Webuye, 
Teso, Kitale, Kapenguria, Mt. Elgon, Hen, Kabarnet, 
Busia, Port Victoria, Uasin-Gishu and Khuyangu), 
located within district hospitals and health centres 
throughout Western Kenya. HIV care is provided by 
paeditricians, medical ofﬁcers and clinical ofﬁcers 
trained and mentored within AMPATH. 
Study population: Eligible patients included any child 
seen in any of 18 USAID-AMPATH clinics between 
June 2002 and April 2008 who was HIV-infected and 
less than 15 years of age.
Clinical procedures: Throughout the period of the 
study, clinicians followed detailed, locally developed 
protocols consistent with World Health Organisation 
guidelines. HIV infection was documented by DNA-
PCR (Amplicor, Roche, Basel, Switzerland) for children 
<18 months and by two parallel HIV rapid ELISA tests 
using Determine and Unigold kits for children >18 
months. cART was initiated for any children <6 years of 
age with a CD4 cell percentage of <15%, for any child 
>6 years of age with a CD4 count <200 cells/mm3, and 
for all children with WHO clinical stages 3 or 4 or CDC 
stage C disease. The standard initial cART regimens 
used were zidovudine/lamivudine/nevirapine for 
those weighing <10kg or stavudinel/amivudine/
nevirapine for those weighing >10 kg. All patients 
were started on cotrimoxazole preventive therapy if 
below the age of six years. Those above six years of 
age with a CD4 % of less than 25% and those with 
WHO stages 3 or 4 were also put on cotrimoxazole. 
Children started on cART were seen two weeks 
after initiation of therapy, and then every month 
thereafter. During these visits, patients undergo 
clinical assessments, including assessment of family 
and social characteristics, nutritional status, the 
degree of immuno-suppression, current or chronic 
infections, dietary intake, drug/treatment history 
and adherence history. Laboratory investigations 
included routine assessment of CD4% every six 
months and investigations to evaluate haemoglobin 
level, liver, kidney functions every three months. 
Tests to evaluate for toxicities were performed as 
necessary. Loss to follow-up was deﬁned as missing 
clinic appointment for more than six months for those 
not on cART and more than three months for those 
on cART. An orphan was deﬁned as a child who had 
lost either both or one of the parents. Nutritional 
status was deﬁned using the following categories: 
a weight-for-age Z score (WAZ) of >1 indicated 
normal nutritional status, a WAZ score of -1 to -2 
indicated mild malnutrition, a WAZ score of -2 to -3 
indicated moderate malnutrition, and a WAZ score 
of <3 indicated severe malnutrition. 
Data collection and management: Clinicians completed 
standard initial and return encounter forms at all 
USAID-AMPATH clinic visits for the children  (http://
amrs.iu-Kenya.org/download/forms). The initial encounter 
form included standard demographic; birth and 
prevention of mother to child transmission prophylaxis 
history; dietary intake; social; physical; examination; 
laboratory data and medications provided including 
antiretroviral drugs and opportunistic infection 
prophylaxis. At each subsequent clinical encounter, 
follow-up data were collected on inter-current 
symptoms, medication adherence, new diagnoses, 
laboratory data, and modiﬁcations in medication 
regimens. Dedicated data entry clerks entered this 
information into the ambulatory USAID-AMPATH 
Medical Record System with data entry validated by 
random review of 10% of the data entered. The medical 
records system was MS  Access-based (Microsoft 
Corporation, Redmond, WA) until 2006, and currently 
uses MySQL based database. 
Statistical methods: Descriptive statistics such as mean, 
standard deviation, median and range were used for 
the continuous variables while frequency listings were 
used for categorical variables. The chi-square test was 
used to assess any association between a categorical 
variable and each of the independent variables, where 
the cell count were below 10 the Fishers’ exact test 
was used in 2 by 2 tables. Plots were used to explore 
the trends of the CD4% of children over time, and this 
was done both overall and by orphan status, since 
orphan status was hypothesized to have an effect 
on the trend. All statistical analyses were performed 
using SAS Institute version 9.1. A p-value of less than 
0.05 was considered signiﬁcant in all analyses. 
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RESULTS
Data were available for 4017 HIV-infected children 
who were seen in the USAID-AMPATH outpatient 
HIV clinics from June 2002 to April 2008. The majority 
of patients were enrolled at the outpatient HIV clinic 
at the urban outpatient clinic of Moi Teaching and 
Referral Hospital (33%) with the remaining patients 
enrolled at district hospitals and rural health centres 
(Table 1). The median age at enrollment was 4.5 
years (range: 0 years-14.2 years), with the median 
duration of follow-up being 15 months (range: 0.00-
74 months). At enrollment, 10% of the children were 
less than ﬁve months old, almost 50% were between 
ﬁve months and ﬁve years old, and 40 % were older 
than ﬁve years. About half of the children were girls 
(51%). A total of 59% were orphaned at enrollment: 
25% being paternal orphans, 13% maternal and 11% 
total orphans. The predominant ethnic group of the 
children was Luhya (32%) with the rest being Kalenjin 
(27%), Luo (20%), Kikuyu (10%) and others. At the 
time of cART initiation, more than half of the children 
on cART were brought to the clinic by their mothers 
(52%), 14% by their grandparents, 11.5% by an auntie 
or uncle and only 8% by their fathers. The majority of 
children had less than two siblings (53%), with only 
14% having ﬁve or more siblings. 
Table 1
Demographic characteristics of children
 No. (%)
Gender 
  Male  1959 48.78
  Female  2057 51.22
Clinic  
  MTRH  1307  32.54 
  MRHC  343  8.54 
  Turbo  236  5.88 
  Burnt Forest 219  5.45 
  Chulaimbo  353  8.79 
  Webuye  223  5.55 
  Kitale  345  8.59 
  Busia  158  3.93 
  Distant clinics 833  20.74 
Orphaned status  
  Paternal  995  24.77 
  Maternal  536  13.34 
  Total  428  10.65 
  Non orphaned  1145  22.73 
  Unknown  913  28.50 
Conﬁrmed dead?   
  Yes  224 5.58
  No  3793 94.42
Ever On ARVs?  
  Yes  2576 64.13
  No  1441 35.87
Child attended school  
  Yes  882 41.25
  No  247 11.55
  Non-applicable  1009 47.19
  Missing  1879 
Clinical status at presentation: The majority (78%) of the 
children over nine months of age had completed their 
immunisations as deﬁned by the Kenya Expanded 
Programme of Immunization (KEPI) schedule. More 
than a quarter (25%) of the patients had normal WAZ 
scores at enrollment, another one quarter (26%) had 
mild malnutrition, 26% had moderate malnutrition, 
and 22% were severely malnourished (Table 2).
  
Table 2
Anthropometric measures (n=4017)
 No. (%)     
Age at enrolment in categories 
  <5 months  410  10.60 
  5 months- 1 year  328  8.48 
  1 to 5 years  1549  40.04 
  5-12 years  1462  37.79 
  12-15 years  120  3.10 
Age at start of ART in categories 
  <1 year  146 5.68
  1 to 5 years  1050 40.87
  5-12 years  1248 48.58
  12-15 years  125 4.87
WAZ score closest to enrolment (n=3724)
  < 3  816 21.91
  -3 to -2  982 26.37
  2 to -1  990 26.58
  > 1  936 25.13
  Missing  170
WAZ score at last 
appointment (n=3765)
  < 3  535 14.21
  -3 to -2  843 22.39
  -2 to -1  1220 32.40
  > 1  1167 31.00
  Missing  129
There was a statistically signiﬁcant difference between 
the nutritional status of non-orphaned children 
compared to the orphaned children at enrollment 
(p=0.0001), with orphaned children having more 
malnutrition (Table 3). 
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More than two thirds of the children were either 
asymptomatic or mildly symptomatic at enrollment 
(56%), with only 26% being in WHO stages 3 and 18% 
in WHO stage 4 (Table 4). The most common presenting 
symptoms and diagnoses at enrollment were rash/
dermatitis (32%), cough (25%), gastroenteritis (21%), 
fever (15%), pneumonia (10%), otitis media (8%), 
oral thrush (8%), failure to thrive (6%), and delayed 
milestones (2.5%). Slightly more than one quarter 
had been diagnosed with tuberculosis (TB) at some 
time point either before or after enrollment.  Only 
one quarter (24%) had ever been on cotrimoxazole 
for pneumocystis carinii prophylaxis (Table 4). 
Table 4
Clinical diagnoses and signs and symptoms (n=4017)
  No. (%)      
WHO staging at 
enrolment (n=3844)    
  Stage 1  957  24.90 
  Stage 2  1193  31.04 
  Stage 3  998  25.96 
  Stage 4  696  18.11 
  Missing  173  
WHO staging at last 
appointment (n=3844)  
  Stage 1  695  18.08 
  Stage 2  895  23.28 
  Stage 3  964  25.08 
  Stage 4  1290  33.56 
  Missing  173  
Develop TB? (n=4017)  
  Yes  1083  26.96 
  No  2934  73.04 
Table 3
Comparing nutritional status by orphan status
Variable  Orphan  Non-orphan  P-value 
 No.  (%) No.  (%)
WAZ score at ﬁrst appointment  (n=941)  (n=1755) 
< 3  192  20.40  421  23.99  <0.0001
-3 to-2  291  30.92  417  23.76 
-2 to -1  278  29.54  434  24.73 
> 1  180  19.13  483  27.52 
WAZ score at last appointment  (n=948)  (n=1722)  <0.0001
< 3  109  11.50  305  17.21 
-3 to-2  348  26.90  376  21.22 
-2 to-l  468  35.97  523  29.51 
> 1  296  25.63  568  32.05
Develop TB? (n=1083)  
  At enrolment  215  19.85 
  After enrolment  868  80.15 
Develop TB? (n=1083)  
  After ARV  174  16.07 
  Before ARV  559  51.62 
  Never on ARV  350  32.32 
Hospitalisation   
  Yes  778  19.38 
  On septrin  978  24 
Over 9 months (n=3702)  
  Completed immunisation  2898  
Table 5
Laboratory tests
CD4% closest to enrolment (n=2975) 
  Mean (sd) 17.49 (10.96) 
  Median (range)  16.00 (0,64) 
CD4% at last appointment (n=3273) 
  Mean (sd)  22.08 (10.41) 
  Median (range)  22.00 (0.64) 
CD4 count closest to enrollment (n=3275) 
  Mean (sd)  639.56 (587.58) 
  Median (range)  484 (0.4337) 
CD4 count at last appointment (n=3317) 
  Mean (sd)  815 (588) 
  Median (range)  703(0.4262) 
WBC at closest to enrolment (n=984) 
  Mean (sd)  7619 (4247) 
  Median (range)  6776 (102,30000) 
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Hgb at closest to enrolment (n=2851) 
  Mean (sd)  14.55 (226) 
  Median (range)  10.40
  (0.10.70,12100) 
ALC at closest to enrolment  (n=578) 
Mean (sd)  3829.58
  (2898.35) 
Median (range)  3310(1.58,4600) 
Clinical and immunologic course: By the time of the 
last appointment in the database, there was an 
improvement in nutritional status for most children 
(Table 3). Orphaned children continued to be 
more likely to be malnourished (were time, with 
signiﬁcantly lower WAZ scores at the most recent 
assessment of nutritional status (p=0.0001). 
 Of the 1043 diagnosed with TB, the majority 
(80%) were diagnosed after enrollment. The majority 
of the children who developed TB were diagnosed 
with TB prior to initiation of cART (52%) compared 
to 16% who developed TB while on cART. 
 The median CD4 count and percentages closest to 
enrollment were 484 (range: 1-4337) and 16% (range: 
0-64%) respectively (Table 6). 
 The median CD4 count and percentage increased 
slightly when examining the most recent clinical 
measurement, 703 (range 1-4262) and 22% (range 
0-64) respectively (Figures 1 and 2). Orphan status 
did not affect these trends. (Figures 3 and 4). 
Figure 1
CD4 percent proﬁle for children on ART
Figure 2
CD4 percent proﬁle for children not on ART
Anti-retroviral therapy and opportunistic infections 
prophylaxis status: About two thirds (64%) of all HIV 
-infected children were on cART during the period 
of the study. The median age at start of the cART 
was 5.3 years (range: 0-14.4 years). Only 6% of the 
children on ART were below one year of age, 41% 
between one and ﬁve years, and more than half (52%) 
above ﬁve years. 
 The children started on cART had a median 
CD4 count and percent of 375 (range 1-4202) and 
13% (range 0-62%) respectively closest to enrollment. 
Those not on ART had higher counts of 814 (range 
0-4331) and 24% (range 0-64%) respectively closest 
to enrollment (Table 6). The median CD4 counts 
increased at the last appointment for those on cART 
to 671 (range 0-4262) and 22% (range 059). However, 
these values declined slightly in those not on cART 
to 787 (range 0-3940) and 23 (range 0-64) respectively. 
(Figures l and 2) Among those on cART, orphaned 
children tended to have a lower latest recorded CD 
4% compared to the non-orphaned (Figure 3). The 
trends of CD4 percent did not vary much between 
the different age categories (Figure 5).
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Figure 3
Median CD4 percent for those on ART by orphan status
Figure 4
Median CD4 percent for those not on ART by orphan 
status
Figure 5
Median CD4 percent for children on cART with age
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Follow-up and admission characteristics: A quarter (26%) of 
the children were lost to follow-up during the duration 
of follow-up, with 19% of those on cART being lost to 
follow-up compared to slightly over one third (37%) 
for those not on cART. Only 6% were conﬁrmed dead 
after enrollment. 
 About one ﬁfth of the children (19%) were ever 
admitted after enrollment to various hospitals in 
the vicinity of AMPATH clinics during the study 
period. Ninety one patients were admitted to the 
biggest and referral facility in the programme, MTRH. 
Documentation for admission to other peripheral 
health facilities was incomplete and was not included. 
The most common reasons for admission at MTRH 
were pneumonia (n=60), malaria (n=22), pulmonary 
tuberculosis (n=14), meningitis (n=9), dehydration (n=9) 
and malnutrition (n=5). Of those admitted in MTRH, 
24 died and the rest were discharged. One third (32%) 
of all those admitted had ever been on cART. 
DISCUSSION
In this retrospective study, we describe the characteristics 
of a large cohort of HIV infected children in sub-Saharan 
Africa. The most common presenting symptoms and 
diagnoses in this cohort compares well with other 
African cohorts (8,9). Skin rash; chronic or recurrent 
cough probably associated with tuberculosis, lymphoid 
interstitial pneumonitis and upper respiratory tract 
infections; gastroenteritis and oral thrash formed some 
of the common presenting features. Interestingly, only 
26% of the children seen in this cohort were diagnosed 
with tuberculosis before and after enrollment. This is 
low compared to estimated rates of TB in other children 
populations in Africa (9). However, this may be an 
indication that we are under-diagnosing tuberculosis 
in children, a well recognised challenge in resource 
limited settings where diagnostic capabilities are still 
limited and criteria for diagnosing TB still not well 
validated in the background of HIV infection (14). 
 A majority of the children presented at a relatively 
good WHO clinical stage, emphasizing the fact that 
our local population may be heeding the call by 
health personnel, community mobilisers and media 
for the affected families to present early for testing 
and care. In addition, this means that the children in 
our cohort are identiﬁed early for care. In contrast 
to early literature describing late presentation of 
African children (7-9), we are only seeing about 40% 
in WHO stages 3 and 4 at presentation. The rapid 
progression of HIV in children may be explained by 
the level of maturity of the immune system at the 
time of HIV acquisition. Infants with HIV are also 
exposed to primary infections and opportunistic 
organisms which is different from the reactivation 
of such infections that occurs in adults. 
 Early enrollment to paedriatic HIV care will 
translate to early treatment of opportunistic infections 
and early initiation on ART and therefore better survival 
(15,16). We however noted a low uptake of cotrimoxazole 
preventive therapy. This may be explained by the fact 
that almost half of the children have a good clinical and 
immunological status and therefore did not qualify for 
CPT. We have however also noted a lack of compliance to 
the protocols by some clinicians. This is being addressed 
by retraining and mentoring of the clinicians. We are also 
in the process of introducing electronically generated 
reminders to clinicians to initiate all eligible children 
on CPT. This will deﬁnitely help reduce the morbidity 
and mortality from common conditions prevalent in 
this population of children as has been described in 
Zambian children (17).
 In this cohort, the majority of children receiving 
care in the comprehensive clinics in Western Kenya 
are the under-ﬁves, indicating the increased ability of 
prevention of mother to child service and other entry 
Table 6
CD4 by ARV status
 Ever on ARV Not on ARV
CD4% closest to enrolment  (n=2107)  (n=868)
Mean (sd)  14.66 (9.84)  24.38 (10.48)
Median( range)  13.00 (0.62)  24 (0.64)
CD4% at last appointment  (n=2380)  (n=893) 
Mean (sd)  21.66 (10.64) 23.20 (9.70)
Median (range) 22 (0,59.00) 23.0 (0.64)
CD4 count closest to enrolment (n=2380) (n=900)
Mean (sd)  505.54 (475.44) 992.93 (698.12)
Median( range)  375 (1.4202) 814 (0.4331)
CD4 count at last appointment  (n=2406) (n=911)
Mean (sd)  768.77 (558.79) 935.01 (646.57)
Median(range)  671.5 (1.4262)   787 (0.3940) 
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points in identifying the infants early and starting 
them on co-trimoxazole and follow-up. This might 
explain the relatively low crude mortality in this cohort. 
Early infant diagnosis is known to prevent morbidity 
and mortality as has been described in studies in 
South Africa and Uganda (15,19). In the AMPATH 
programme, the pMTCT programme was ramped 
up in 2002-2004 leading to early clinic attendance in 
index children and their siblings (13). We therefore 
demonstrate that it is possible to diagnose these 
children early despite the often reported delays in early 
diagnosis in resource limited settings. The use of all 
points of entry including ante natal clinic, outpatient 
clinics, TB clinics and wards for paedriatic diagnosis 
is not reported in many care settings. In Uganda and 
South Africa (18,19) efforts in ANC and outpatient 
clinics reported improvements in the rate of early 
diagnosis comparable to what we ﬁnd in this study. 
More resources and targets need and can be set aside 
to achieve this lifesaving objective in programmes in 
low income countries. 
 The immunologic status of the children was 
also relatively good unlike the ﬁndings of the adult 
population in the same care and in other studies 
in Africa (20). Immunologic status was lower at 
enrollment for those started on ART. The median CD4 
count and percentage was lower when we looked at 
the most recent counts for those not on ART and, as 
expected, was higher in those on ART in recent counts. 
This suggests the success of ART in this cohort, and 
matches the previous analyses of an earlier cohort 
(12) and other African cohorts (20). The trends of CD4 
percent in different age categories did not vary much 
(Figure 5). One would have expected a more rapid 
decline for those below one year of age. This is perhaps 
explained by the consistent follow-up, prevention and 
treatment of opportunistic diseases in these children 
thus maintaining a relatively good CD4 percent. 
 The nutritional status of the children was 
relatively good at enrollment. It was signiﬁcantly 
lower at enrollment for those who subsequently began 
ART. The status was also signiﬁcantly lower among 
orphaned children compared with the non-orphaned, 
a feature that has been noted in an earlier cohort in 
the same programme on ART (12). In that study, the 
orphaned children seemed to lag in improvement of 
their nutritional status compared to the non-orphaned 
after 100 weeks of follow-up. In the current analysis, 
nutritional status improved in both groups albeit a 
small lag of the latest values for the orphaned on cART, 
which may reﬂect the impact of nutritional support 
for families that is now provided in this programme 
(13). In this nutritional programme, children with 
malnutrition or food insecurity as assessed by the 
nurses or nutritional assistants at each visit are initiated 
on food rations that include pulses and oil (provided 
by World Food Program) and vegetables (provided 
from USAID-AMPATH demonstration farms) until 
there is improvement in the nutritional status and 
food security situation. This is an important ﬁnding 
that requires more investigation on the effect of good 
nutrition in delaying initiation of ART in children. 
 The median haemoglobin level at enrollment 
in this cohort was relatively high at 10gm/dl. This 
is a reassuring ﬁnding in such a young population, 
particularly since a signiﬁcant number of the children 
are using zidovidune, a potential bone marrow 
suppressant. In addition, the median white cell count 
and absolute lymphocyte counts were relatively high, 
though lower in the group that was started on ART. 
There were no signiﬁcant differences in the absolute 
lymphocyte counts from different geographical and 
therefore ethnic sites, as contrast to ﬁndings in the 
adult population in the same programme (unpublished 
data, under review at EAMJ). 
 Less than one quarter of the patients were ever 
admitted to hospital. The most common reasons for 
admission of the cohort seen at MTRH were pneumonia, 
gastroenteritis, malaria, pulmonary tuberculosis and 
meningitis. These ﬁndings are similar to those in other 
African countries (8,9,20,21). Mortality was low in this 
cohort, reﬂecting relatively good care in a resource-
constrained setting. However, there is a high loss to 
follow-up, and it is difﬁcult to say whether some of 
these might be unreported deaths. The children on 
cART are less likely to be lost to follow-up and this 
is probably evidence of sustained education, support 
and follow-up that is accorded to children on cART 
by the caregivers and care providers. The difﬁculty 
associated with inability to trace our patients is a 
common feature in Africa where homes do not have 
well deﬁned location. This is however being addressed 
in an outreach programme within USAID-AMPATH, 
and we hope to have less loss to follow-up and better 
data on mortality form this cohort in the future. 
 The majority are brought to the clinic by their 
mothers as is cultural in African countries. However, 
the grandparents, aunts and uncles also playa key role 
in bringing HIV infected children for care in those that 
are orphaned. This has been described in other African 
cohorts where the extended families have been able to 
lessen the burden that the orphans would otherwise 
face (22). More than two thirds of the children seen in 
this cohort are orphaned, with more than 10% having 
both parents’ dead. This is consistent with the high 
prevalence of orphan-hood within Kenya. Other 
studies in African countries report higher rates of 
orphan-hood (22). Within this population, more 
children have lost their fathers than their mothers. 
This may reﬂect that women seek healthcare earlier 
than men as reported in WHO bulletins. In addition, 
the higher prevalence of paternal orphans may 
spring from earlier HIV infection, progression, and 
death among men compared to women (22).
 This cohort describes ﬁndings in children that 
have access to a comprehensive package including 
nutritional support, micro-enterprise programmes 
to families to facilitate income generation, and free 
drugs, including ART and drugs for opportunistic 
infections. It may therefore not be representative, 
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at least in terms of disease progression in other 
resource-limited settings, including those run by 
the Kenyan Ministry of Health. In addition, the high 
rate of LTFU may affect the ﬁndings of this study. 
In conclusion, we note that HIV -infected children 
were enrolled in care early in childhood. Orphan-
hood was prevalent in these children as were 
gastroenteritis, fever, pneumonia and advanced 
immuno-suppression. Orphans were more likely to 
be severely malnourished. Only a quarter of children 
were put on contimoxazole preventive therapy. 
Children commenced on cART late but responded to 
treatment well. Loss to follow-up was less prevalent 
among those on cART.
 We recommend long term follow-up of children 
in this and other similar settings to determine the 
natural progression for those on ART and those not 
on ART. The nutritional status of orphaned children 
needs to be assessed more aggressively and managed 
early. Efforts to increase uptake of cotrimoxazole 
preventive therapy and decrease the loss to follow-
up need to be intensiﬁed. 
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